Farhad Peerani

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Walter FRIES

Professore Ordinario di gastroenterologia

Università degli Studi di Palermo

ITALY

View details

Jakob Seidelin

Københavns Universitet

DENMARK

View details

Gregory Thomas Charles Moore

MONASH UNIVERSITY

AUSTRALIA

View details

Samuel Huber

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Christopher Ma

Assistant Professor

University of Calgary

CANADA

View details

Bu'Hussain Hayee

Professor in Gastroenterology

King’s College London

UNITED KINGDOM

View details

Karen Kroeker

University of Alberta

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Farhad Peerani

Research Interests

Explore related searches

Contact this professor

Articles (14)

The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review

Integrating Virtual Mindfulness-Based Stress Reduction Into Inflammatory Bowel Disease Care: Mixed Methods Feasibility Trial

Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study)

Resolution of Rectal Bleeding by Day 7 in Acute Severe Ulcerative Colitis Is Prognostic for Postdischarge Corticosteroid-Free Clinical Remission and Endoscopic Improvement

REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis

Microbial-Immune Crosstalk in Elderly-Onset Inflammatory Bowel Disease: Unchartered Territory

REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis A Canadian IBD Research Consortium Multicenter National Cohort Study

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease.

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Editorial: <scp>IBD</scp> and the risk of dementia ‐ the jury is still out

Editorial: IBD and the risk of dementia - the jury is still out

Association Between Frailty or Sarcopenia and Adverse Outcomes in Inflammatory Bowel Disease: A Systematic Review

Collaborators (7)

Walter FRIES

Jakob Seidelin

Gregory Thomas Charles Moore

Samuel Huber

Christopher Ma

Bu'Hussain Hayee

Karen Kroeker

Make your next move.